Selected research
Industry Research
Animal Antibacterial Peptide Industry Research Report 2026
Market perspective
The global Animal Antibacterial Peptide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Animal Antibacterial Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Animal Antibacterial Peptide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Animal Antibacterial Peptide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Animal Antibacterial Peptide include Animal Medics, Biogenesis Bago, Boehringer Ingelheim Vetmedica, Elanco (Eli Lilly and Company), Merial, Zoetis, Bayer HealthCare and Merck Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Animal Antibacterial Peptide market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Antibacterial Peptide Market by Company
Animal Medics
Biogenesis Bago
Boehringer Ingelheim Vetmedica
Elanco (Eli Lilly and Company)
Merial
Zoetis
Bayer HealthCare
Merck Animal Health
Animal Antibacterial Peptide Segment by Type
Anionic Peptides
Cationic Peptide
Animal Antibacterial Peptide Segment by Application
Poultry
Livestock
Animal Antibacterial Peptide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Antibacterial Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Antibacterial Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Antibacterial Peptide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal Antibacterial Peptide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal Antibacterial Peptide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal Antibacterial Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anionic Peptides
- Cationic Peptide
Applications
- Poultry
- Livestock
Companies covered
- Animal Medics
- Biogenesis Bago
- Boehringer Ingelheim Vetmedica
- Elanco (Eli Lilly and Company)
- Merial
- Zoetis
- Bayer HealthCare
- Merck Animal Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Animal Antibacterial Peptide Market Size (2021-2032)
- 2.2.2 Global Animal Antibacterial Peptide Sales (2021-2032)
- 2.2.3 Global Animal Antibacterial Peptide Market Average Price (2021-2032)
- 2.3 Animal Antibacterial Peptide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Anionic Peptides
- 2.3.3 Cationic Peptide
- 2.4 Animal Antibacterial Peptide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Poultry
- 2.4.3 Livestock
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Animal Antibacterial Peptide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Animal Antibacterial Peptide Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Animal Antibacterial Peptide Revenue of Manufacturers (2021-2026)
- 3.4 Global Animal Antibacterial Peptide Average Price by Manufacturers (2021-2026)
- 3.5 Global Animal Antibacterial Peptide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Animal Antibacterial Peptide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Animal Antibacterial Peptide, Product Type & Application
- 3.8 Global Manufacturers of Animal Antibacterial Peptide, Established Date
- 3.9 Global Animal Antibacterial Peptide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Animal Medics
- 4.1.1 Animal Medics Company Information
- 4.1.2 Animal Medics Business Overview
- 4.1.3 Animal Medics Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Animal Medics Animal Antibacterial Peptide Product Portfolio
- 4.1.5 Animal Medics Recent Developments
- 4.2 Biogenesis Bago
- 4.2.1 Biogenesis Bago Company Information
- 4.2.2 Biogenesis Bago Business Overview
- 4.2.3 Biogenesis Bago Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Biogenesis Bago Animal Antibacterial Peptide Product Portfolio
- 4.2.5 Biogenesis Bago Recent Developments
- 4.3 Boehringer Ingelheim Vetmedica
- 4.3.1 Boehringer Ingelheim Vetmedica Company Information
- 4.3.2 Boehringer Ingelheim Vetmedica Business Overview
- 4.3.3 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product Portfolio
- 4.3.5 Boehringer Ingelheim Vetmedica Recent Developments
- 4.4 Elanco (Eli Lilly and Company)
- 4.4.1 Elanco (Eli Lilly and Company) Company Information
- 4.4.2 Elanco (Eli Lilly and Company) Business Overview
- 4.4.3 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product Portfolio
- 4.4.5 Elanco (Eli Lilly and Company) Recent Developments
- 4.5 Merial
- 4.5.1 Merial Company Information
- 4.5.2 Merial Business Overview
- 4.5.3 Merial Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merial Animal Antibacterial Peptide Product Portfolio
- 4.5.5 Merial Recent Developments
- 4.6 Zoetis
- 4.6.1 Zoetis Company Information
- 4.6.2 Zoetis Business Overview
- 4.6.3 Zoetis Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zoetis Animal Antibacterial Peptide Product Portfolio
- 4.6.5 Zoetis Recent Developments
- 4.7 Bayer HealthCare
- 4.7.1 Bayer HealthCare Company Information
- 4.7.2 Bayer HealthCare Business Overview
- 4.7.3 Bayer HealthCare Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer HealthCare Animal Antibacterial Peptide Product Portfolio
- 4.7.5 Bayer HealthCare Recent Developments
- 4.8 Merck Animal Health
- 4.8.1 Merck Animal Health Company Information
- 4.8.2 Merck Animal Health Business Overview
- 4.8.3 Merck Animal Health Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merck Animal Health Animal Antibacterial Peptide Product Portfolio
- 4.8.5 Merck Animal Health Recent Developments
5 Global Animal Antibacterial Peptide Market Scenario by Region
- 5.1 Global Animal Antibacterial Peptide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Animal Antibacterial Peptide Sales by Region: 2021-2032
- 5.2.1 Global Animal Antibacterial Peptide Sales by Region: 2021-2026
- 5.2.2 Global Animal Antibacterial Peptide Sales by Region: 2027-2032
- 5.3 Global Animal Antibacterial Peptide Revenue by Region: 2021-2032
- 5.3.1 Global Animal Antibacterial Peptide Revenue by Region: 2021-2026
- 5.3.2 Global Animal Antibacterial Peptide Revenue by Region: 2027-2032
- 5.4 North America Animal Antibacterial Peptide Market Facts & Figures by Country
- 5.4.1 North America Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Animal Antibacterial Peptide Sales by Country (2021-2032)
- 5.4.3 North America Animal Antibacterial Peptide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Animal Antibacterial Peptide Market Facts & Figures by Country
- 5.5.1 Europe Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Animal Antibacterial Peptide Sales by Country (2021-2032)
- 5.5.3 Europe Animal Antibacterial Peptide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Animal Antibacterial Peptide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Animal Antibacterial Peptide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Animal Antibacterial Peptide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Animal Antibacterial Peptide Market Facts & Figures by Country
- 5.7.1 South America Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Animal Antibacterial Peptide Sales by Country (2021-2032)
- 5.7.3 South America Animal Antibacterial Peptide Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Animal Antibacterial Peptide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Animal Antibacterial Peptide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Animal Antibacterial Peptide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Animal Antibacterial Peptide Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Animal Antibacterial Peptide Sales by Type (2021-2032)
- 6.1.1 Global Animal Antibacterial Peptide Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Animal Antibacterial Peptide Sales Market Share by Type (2021-2032)
- 6.2 Global Animal Antibacterial Peptide Revenue by Type (2021-2032)
- 6.2.1 Global Animal Antibacterial Peptide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Animal Antibacterial Peptide Revenue Market Share by Type (2021-2032)
- 6.3 Global Animal Antibacterial Peptide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Animal Antibacterial Peptide Sales by Application (2021-2032)
- 7.1.1 Global Animal Antibacterial Peptide Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Animal Antibacterial Peptide Sales Market Share by Application (2021-2032)
- 7.2 Global Animal Antibacterial Peptide Revenue by Application (2021-2032)
- 7.2.1 Global Animal Antibacterial Peptide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Animal Antibacterial Peptide Revenue Market Share by Application (2021-2032)
- 7.3 Global Animal Antibacterial Peptide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Animal Antibacterial Peptide Value Chain Analysis
- 8.1.1 Animal Antibacterial Peptide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Animal Antibacterial Peptide Production Mode & Process
- 8.2 Animal Antibacterial Peptide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Animal Antibacterial Peptide Distributors
- 8.2.3 Animal Antibacterial Peptide Customers
9 Global Animal Antibacterial Peptide Analyzing Market Dynamics
- 9.1 Animal Antibacterial Peptide Industry Trends
- 9.2 Animal Antibacterial Peptide Industry Drivers
- 9.3 Animal Antibacterial Peptide Industry Opportunities and Challenges
- 9.4 Animal Antibacterial Peptide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst